The Indiana University School of Medicine Department of Neurological Surgery, under the leadership of Mitesh V. Shah, MD intends to lead Indiana, the Midwest and beyond in the care of patients with nervous system disorders using state-of-the-art technology and advanced techniques in the operating room and clinic—doing so in a compassionate and caring environment that emphasizes quality and safety. Neurosurgery clinicians, researchers and educators at IU School of Medicine are at the forefront among national leaders in how they treat patients, investigate new therapeutics and train the next generation of neurosurgeons.


Clinical Care
Department faculty are advancing the health of adults and children with neurosurgical disorders with a unique, patient-first approach to brain, spine and nerve care.

Research
Through clinical and laboratory research studies and more, neurological surgery faculty researchers dedicate their life’s work to advancing treatment solutions for patients.

Education
Internationally renowned faculty neurosurgeons at IU School of Medicine provide training to medical students, residents and fellows pursuing subspecialty expertise.
Recent News
Neuroscience experts collaborate to advance minimally invasive procedure to treat movement disorders
Stereotactic and functional neurosurgery specialists in the Department of Neurological Surgery and movement disorder specialists in the Department of Neurology have been performing the deep brain stimulation procedure since 1997, providing life-altering treatments for patients with neurological disorders.July 31, 2025
End of an era: Neurological Surgery education director retires after 43 years of service
After more than four decades with IU School of Medicine, beloved Education Director Mary Gallagher will be saying farewell to the Department of Neurological Surgery.July 28, 2025
IU neuroscientist studying potential drug targets for debilitating tumors that grow on nerves
Jignesh Tailor hopes his studies into the role of NF2 gene mutation in neural stem cell differentiation failure and tumorigenesis will lead to new therapeutics for children living with the rare genetic condition.
May 06, 2025